BL
MIST icon

Bleichroeder LP’s Milestone Pharmaceuticals MIST Stock Holding History

Bleichroeder LP’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500,000
Closed -$970K – 77
2025
Q2 		$970K Hold
500,000
– – 0.24% 34
2025
Q1 		$400K Sell
500,000
-826,085
-62% -$1.64M 0.11% 47
2024
Q4 		$3.13M Hold
1,326,085
– – 0.79% 18
2024
Q3 		$2.02M Hold
1,326,085
– – 0.54% 23
2024
Q2 		$1.75M Hold
1,326,085
– – 0.52% 22
2024
Q1 		$2.37M Hold
1,326,085
– – 0.59% 22
2023
Q4 		$2.21M Hold
1,326,085
– – 0.49% 22
2023
Q3 		$4.11M Hold
1,326,085
– – 1.01% 19
2023
Q2 		$3.78M Hold
1,326,085
– – 0.77% 23
2023
Q1 		$5.22M Hold
1,326,085
– – 1.11% 18
2022
Q4 		$5.25M Buy
1,326,085
+813,585
+159% +$4.28M 1.14% 19
2022
Q3 		$4.71M Hold
512,500
– – 0.98% 23
2022
Q2 		$3.04M Buy
512,500
+262,500
+105% +$1.61M 0.63% 30
2022
Q1 		$1.6M Hold
250,000
– – 0.28% 39
2021
Q4 		$1.64M Buy
+250,000
New +$1.5M 0.26% 47

Other funds holding MIST

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Bleichroeder LP's MIST Position: Q3 2025 in Review

Bleichroeder LP sold out of Milestone Pharmaceuticals (MIST) in Q3 2025, closing a stake of 500,000 shares — an estimated $970K sold.

Bleichroeder LP first reported a position in MIST in Q4 2021 and held it in 15 quarters. The position peaked at $5.25M in Q4 2022. 61 funds tracked by Wall St. Rank hold MIST as of Q3 2025.

  • Bleichroeder LP reported no remaining Milestone Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Bleichroeder LP sold 500,000 Milestone Pharmaceuticals shares in Q3 2025, an estimated $970K.
  • Bleichroeder LP first reported a position in Milestone Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Bleichroeder LP's Milestone Pharmaceuticals position peaked at $5.25M in Q4 2022.
  • 61 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2025.

Based on Bleichroeder LP's 13F filing for Q3 2025, filed 14 Nov 2025.